CM Life Sciences Inc - Class A
CMLF
Get informed when a big investor buys or sells
+ FollowShare Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-22,464,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.73 |
| Beta | 0 |
| Outstanding Shares | 29,335,126 |
Return
| Return on Equity | -30.62% |
|---|---|
| Return on Assets | -15.37% |
| Return on Invested Capital | -13.22% |
Valuation & Multiples
| P/E Ratio | -4.37 |
|---|---|
| PEG | -0.5 |
| Price to Sales | 0.77 |
| Price to Book Ratio | 1.45 |
| Enterprise Value to Revenue | -0.05 |
| Enterprise Value to EBIT | 0.41 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -3.18 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CM Life Sciences Inc
CM Life Sciences was founded to take advantage of a dynamic life science sector buoyed by innovation yet fragmented, where many companies are under-resourced and under-scaled. Significant and under-appreciated opportunities for consolida...
Relevant Senate Committees
This powerful committee controls taxation (impacting corporate valuations and R&D credits) and influences healthcare through Medicare pricing, which are massive determinants of revenue and profitability for companies in the life science and healthcare sectors.
This committee directly allocates discretionary federal spending, including 'scientific research' funding. These allocations are critical revenue or R&D sources for many life science companies and thus directly impact CMLF's investment targets.
This committee directly regulates the FDA and NIH, which are absolutely central to the pharmaceutical and biotech sectors. Drug approval processes, research funding, and labor laws directly impact CMLF's potential portfolio companies.
CMLF's strategy centers on 'consolidation,' which involves M&A. This committee's oversight of antitrust laws and the DOJ directly impacts the approval and feasibility of mergers, and intellectual property is crucial in life sciences.
This committee directly regulates the financial system, including the SEC, which governs SPACs, public companies, and M&A transactions. This is central to CMLF's operational model and ability to finance consolidation.